Genes are the
part of a body cell that contains the biological information that parents pass
to their children. Genes control the growth and development of cells. Genes are
contained in
DNA (deoxyribonucleic acid), a substance inside the
center (nucleus) of cells that contains instructions for the development of the
cell.
You inherit half of your genetic information from your
mother and the other half from your father. Genes, alone or in combination,
determine what features (genetic traits) a person inherits from his or her
parents, such as blood type, hair color, eye color, and other characteristics,
including risks of developing certain diseases. Certain changes in genes or
chromosomes may cause defects in various body
processes or functions.
What are chromosomes?
Many genes together make up
larger structures within the cell called chromosomes. Each cell normally
contains 23 pairs of chromosomes.1
A
human has 46 chromosomes (23 pairs). One chromosome from each pair comes from
the mother, and one chromosome from each pair comes from the father. One of the
23 pairs determines your sex. The sex chromosomes are called X and Y.
For a child to be female, she must inherit an
X chromosome from each parent (XX).
For a child to be male, he must
inherit an X chromosome from his mother and a Y chromosome from his father
(XY).
Some
genetic disorders are caused when all or part of a
chromosome is missing, or when an extra chromosome or chromosome fragment is
present.
What is genetic testing?
Genetic testing examines
a DNA sample for gene changes, or it may analyze the number, arrangement, and
characteristics of the chromosomes. Testing may be performed on samples of
blood, semen, urine, saliva, stool, body tissues, bone, or hair.
Should I have genetic testing?
You may choose to
have genetic testing if you are concerned that you have an increased risk of
having or getting a disease that has a genetic cause. The information you
obtain from the tests may help you make decisions about your life. For example:
If tests determine that you have an increased
risk for passing on a disease to your child, you may choose to have more
genetic testing while you are pregnant (prenatal testing). Or you may decide to
adopt a child.
If tests determine that you have an increased risk
for developing a disease such as
breast cancer, you may make decisions that help lower
your risk for breast cancer.
You may feel reassured if the tests
are normal.
You may decide to have a genetic test during pregnancy to
determine whether your
fetus has a disorder, such as
Down syndrome. Information obtained from the test can
help you decide how to manage your pregnancy.
Genetic testing can
be used to determine the identity of a child's father (paternity). It can also
be used in crime scene investigation.
What are the main types of genetic testing?
There
are five main types of genetic testing:
Carrier identification determines whether people who have a family history of a
specific disease or who are in a group that has an increased chance for that
disease are likely to pass on that disease to their children. Information
obtained from this type of testing can help guide a couple as they make
decisions about pregnancy.
Prenatal testing determines whether a
fetus has a disorder, such as Down syndrome.
Information gained from this type of testing can help guide decisions about how
to manage a pregnancy, including the decision about whether to end the
pregnancy.
Newborn screening checks for various metabolic diseases,
such as
phenylketonuria (PKU). Information obtained from
newborn screening can help guide medical treatment to ensure the best possible
outcome for the baby.
Late-onset disease testing determines whether
you carry a genetic change that increases your risk for developing a disease,
such as breast cancer or
Huntington's disease, later in life. This might be of
interest if you have a relative with the disease. Information obtained from
this type of testing can help you make decisions about preventing or managing
the disease.
Genetic identification (DNA fingerprinting) can be
used to determine paternity, help solve crimes, and identify a body. DNA
fingerprinting is more accurate than dental records, blood type, or traditional
fingerprints.
What are the risks of genetic testing?
The
information obtained from genetic testing can affect your life and the lives of
your family members. The issues involved include:
Psychological. The
emotions you may experience if you learn that you have a greater chance of
having or passing on a serious disease can cause you to feel anxious or
depressed. This may also affect your relationship with your partner or other
family members.
Genetic counseling is recommended prior to genetic
testing.
Medical. A person who tests
positive for a disease-specific gene may decide to use preventive or treatment
options to reduce the impact or severity of the disease. Although many
treatment options are proven effective, others may be potentially dangerous or
of unproven value.
Privacy. Because genetic
testing is expensive, few people are able to afford it without assistance from
their insurance companies. Many people worry that genetic information released
to insurance companies may affect future employment options or insurance
availability. Although many people are fearful of this, it rarely
happens.
Every person carries two
copies of most genes (one copy from the mother and one from the father). A
carrier is a person who has a change in one copy of a gene. The carrier does
not have the genetic disease related to the abnormal gene. A carrier can pass
this abnormal gene to a child.
Carrier identification is a type of genetic testing
that can determine whether people who have a family history of a specific
disease, or who are in a group that has a greater chance of having a disease,
are likely to pass that disease to their children. Information from this type
of testing can guide a couple's decision about having children.
For many genetic disorders, carrier testing can help determine how likely
it is that a child will have the disease:
If both parents carry the abnormal gene, there is a 1-in-4 (25%)
chance that their child will have the disease and a 2-in-4 (50%) chance that
their child will be a carrier of the disease (but will not have it). There is
also a 1-in-4 (25%) chance that the child will not get the abnormal gene and so
will not have the disease nor be a carrier.
If only one parent
carries the abnormal gene, the child has a 1-in-2 (50%) chance of being a
carrier but almost no chance that he or she will have the disease.
Examples of screening tests to identify carriers for
specific genetic disorders include:
Cystic fibrosis carrier screening.
These tests identify the most common changes or mutations in the cystic
fibrosis transmembrane regulator (CFTR) gene. Many couples planning to become
pregnant have this type of screening to determine whether either or both of
them carry a defective CFTR gene.
Sickle cell test. This test is used to identify someone with sickle cell trait. A
person who has sickle cell trait may have a child with sickle cell disease if
his or her partner is also a carrier.
Tay-Sachs test. This test is used to identify
Tay-Sachs carriers. People of Ashkenazi Jewish or
French-Canadian descent who have a family history of
Tay-Sachs disease or who live in a community or
population with a high prevalence of Tay-Sachs disease may choose to be tested
to see if they are a Tay-Sachs carrier.
Genetic testing is
used to determine whether a
fetus has a disease or genetic abnormality such as
Down syndrome or trisomy 18. Information obtained from
this type of testing may help guide decisions during pregnancy.
Other tests are used for prenatal screening to determine whether a fetus
has an increased risk for a genetic disease. These tests can help identify
substances that might indicate a genetic disease. Examples of tests used for
prenatal screening include:
Triple screen test. This
test measures levels of three substances in a pregnant woman's blood that
indicate how likely it is that the fetus has Down syndrome, trisomy 18, or a
neural tube defect.2 The
results of this test are combined with other information (pregnant woman's age,
weight, race, and whether she has diabetes) to estimate the risk of Down
syndrome in the fetus. Sometimes the tests indicate that a fetus is likely to
have Down syndrome but the fetus is unaffected. This is called a
false-positive result. Or sometimes screening tests do
not find the condition when it is present. This is called a
false-negative result. The substances measured in the
triple screen test are:
Estriol (uE3), a hormone produced by the placenta
during pregnancy.
Quad screen test. This
adds another hormone (inhibin A) to the three substances tested for in the
triple screen. The results of this test are combined with the pregnant woman's
age, weight, race, and whether or not she has diabetes to help determine
whether the fetus has a greater chance of having a condition such as trisomy
18, Down syndrome, or a neural tube defect. The results of a quad screen are
generally more accurate than the results of a triple screen.
Fetal ultrasound. This test uses reflected sound waves
to produce a picture of the fetus, the placenta, and
amniotic fluid. It is used to determine whether the
fetus has a structural abnormality, such as a heart defect.
In some cases a combination of screening tests is done in
the first
trimester to look for Down syndrome or trisomy 18.
This is sometimes called
integrated screening. The screening test uses an
ultrasound measurement of the thickness of the fetus's neck (nuchal fold or translucency) and the levels of hCG and a
protein called pregnancy-associated plasma protein A
(PAPP-A). The sensitivity of this screening test is
about the same as that of the second-trimester maternal serum quad
screening.3
If prenatal screening test
results are abnormal, further genetic testing (karyotype)
can be used to examine the size, shape, and number of chromosomes. A karyotype
can be done on cells taken from the placenta (chorionic villus sampling) in the late first trimester or from the amniotic fluid (amniocentesis) in the second trimester. Extra,
missing, or abnormal positions of chromosome pieces can cause problems with
growth, development, and body functions.
Shortly after birth, a blood
sample is taken from a newborn to screen for diseases such as
phenylketonuria (PKU) and congenital
hypothyroidism. This type of testing is important
because treatment is available to improve the health of the child. Newborn
screening is required in the United States, but states vary on which tests they
offer.
Examples of tests used for newborn screening
include:
Phenylketonuria (PKU) screen, which measures the amount of phenylalanine in a baby's
blood. Babies found to have PKU should be put on a special low-protein diet to
prevent mental retardation.
Newborn screening for cystic fibrosis. Levels of immunoreactive trypsinogen (IRT), a digestive
enzyme, are measured from a blood sample. Abnormally high levels of IRT suggest
cystic fibrosis, although further testing is needed to confirm the
diagnosis.
Hemoglobin test, which tests for types
of
hemoglobin in a baby's blood that may indicate
sickle cell trait or
sickle cell disease. Babies who have sickle cell
disease need special medical care throughout their lives to treat the variety
of problems that can be caused by the illness.
Other tests, such as newborn
hearing tests, can tell whether a baby may need future
hearing services or genetic testing. Approximately 50% of cases of newborn
hearing loss are caused by genetic factors.4
This type of testing is done to
determine whether you have a greater chance of having diseases that show up
later in life (late-onset diseases). If you have a relative who has the
disease, information obtained from these tests can help you make decisions
about preventing or slowing the progress of the disease.
Genetic
testing is used to identify the risk of late-onset diseases such as:
Genetic testing used to determine the
biological parent of a child is called
DNA fingerprinting. It is also often used to help
solve crimes by determining whether crime scene DNA evidence could be the same
as the suspect's DNA.
DNA fingerprinting has been used to
identify unknown people, such as military personnel killed in action or crime
victims. DNA fingerprinting is more accurate for this purpose than dental
records, blood type, traditional fingerprinting, or ID tags.
The information obtained from
genetic testing can have a big impact on your life.
Genetic counselors are trained to help you understand
your risk of getting a disease related to genetics or of having a child with an
inherited (genetic) disease, such as
sickle cell disease,
cystic fibrosis, or
hemophilia. A genetic counselor can help you make
well-informed decisions. Ask to have genetic counseling before making a
decision about testing. Genetic counseling may involve:
Discussing what problems an inherited disease
may cause.
Teaching you and your partner about how a specific disease is
inherited or passed from you to your child.
Discussing whether and
how to test for an inherited disease before you become pregnant or before your
child is born.
Discussing the likelihood that you and your partner
will have a child with an inherited disease, based on test results.
Genetic counseling can help you and your family:
Understand medical facts, including what causes
diseases, how a diagnosis is made, and what you may be able to do to help
yourself manage a disease.
Understand how your family history
contributes to the development of a disease.
Understand what you
can do to help prevent a disease.
Learn about caring for a family
member who has a genetic disease, including getting referrals to specialists or
joining support groups.
Genetic counselors are trained to help you and your family
make informed decisions that are right for you. They are sensitive to physical
and emotional aspects of these decisions. Your privacy and confidentiality are
carefully protected.
Before making a decision about
testing, you should clearly understand how the results of the test may affect
your life. Consider how the test results may influence your decisions. If
testing will not change any of your decisions, you may feel the test is not
worth doing.
Fetal genetic testing may detect a serious
disease or disorder, such as
Down syndrome, that will greatly impact your child's
life and the lives of caregivers. A pregnant woman who is considering genetic
testing may want to consider her ethical, social, and religious beliefs to help
her determine the actions she would take if test results show a genetic
disease.
A genetic test result is sensitive information. Your
confidentiality should be maintained, and the release
of information should be limited to those who are authorized to receive
it.
Genetic testing can sometimes reveal unintended information,
such as the identity of a child's father (paternity).
The discovery of a genetic disease may affect your future ability
to get work or some types of private insurance coverage. Although many people
are fearful of this, it rarely happens.
Centers for Disease Control and Prevention (CDC):
National Center on Birth Defects and Developmental Disabilities
(NCBDDD)
1600 Clifton Road
Atlanta, GA 30333
Phone:
1-800-232-4636 (1-800-CDC-INFO)
TDD:
1-888-232-6348
E-mail:
cdcinfo@cdc.gov
Web Address:
www.cdc.gov/ncbddd
NCBDDD aims to find the cause of and prevent birth
defects and developmental disabilities. This agency works to help people of all
ages with disabilities live to the fullest. The Web site has information on
many topics, including genetics, autism, ADHD, fetal alcohol spectrum
disorders, diabetes and pregnancy, blood disorders, and hearing loss.
Genetic Alliance
4301 Connecticut Avenue NW
Suite 404
Washington, DC 20008-2369
Phone:
1-800-336-GENE (1-800-336-4363) (202) 966-5557
Fax:
(202) 966-8553
E-mail:
info@geneticalliance.org
Web Address:
www.geneticalliance.org
The Genetic Alliance is an international organization
made up of millions of people with genetic conditions and more than 600
advocacy, research, and health care organizations that represent their
interests. The Alliance builds partnerships to promote healthy lives for all
those living with genetic conditions.
The Genetic Alliance
promotes healthy lives by working to speed the translation of genetic advances
into quality and affordable health care, public awareness, and
consumer-centered public policies.
National Institutes of Health: Health
Information
9000 Rockville Pike
Bethesda, MD 20892
Phone:
(301) 496-4000
TDD:
(301) 402-9612
E-mail:
NIHinfo@od.nih.gov
Web Address:
http://health.nih.gov
The U.S. National Institutes of Health (NIH) conducts
and supports medical research to improve people's health and save lives. NIH
provides access to health and wellness information, free newsletters, current
research, health databases, fact sheets, and many other resources.
National Library of Medicine: Genetics Home
Reference
8600 Rockville Pike
Bethesda, MD 20894
Phone:
1-888-FIND-NLM (1-888-346-3656) (301) 594-5983
Fax:
(301) 402-1384
TDD:
1-800-735-2258
E-mail:
custserv@nlm.nih.gov
Web Address:
http://ghr.nlm.nih.gov
This Web site has consumer-friendly information about
how human health is affected by genetics. There is information about genetic
conditions, counseling, testing, and research as well as definitions of
mutations, inheritance, and more.
National Tay-Sachs and Allied Diseases Association, Inc.
(NTSAD)
2001 Beacon Street
Suite 204
Boston, MA 02135
Phone:
1-800-906-8723
Fax:
(617) 277-0134
E-mail:
info@ntsad.org
Web Address:
www.ntsad.org
NTSAD is a nonprofit, volunteer health agency devoted to
the treatment and prevention of Tay-Sachs and other genetic conditions. Its Web
site has information about genetic diseases, carrier testing, genetic
counseling, and more. NTSAD has a support group for families and individuals
affected by genetic diseases.
National Cancer Institute (2007). Cancer Genetics Overview (PDQ)—Health Professional Version.
Available online:
http://www.cancer.gov/cancertopics/pdq/genetics/overview/healthprofessional.
Fergal DM, D'Alton ME (2003). First-trimester
sonographic screening for Down syndrome. Obstetrics and Gynecology, 102(5): 1066–1079.
American College of Obstetricians and Gynecologists
(2007). Screening for fetal chromosomal abnormalities. ACOG Practice Bulletin
No. 77. Obstetrics and Gynecology, 109(1): 217–227.
Genetic Evaluation of Congenital Hearing Loss Expert
Panel (2002; reaffirmed 2005). Genetics evaluation guidelines for the etiologic
diagnosis of congenital hearing loss. Genetics in Medicine, 4(3): 162–171.
Other Works Consulted
Elias ER, et al. (2007). Genetics and dysmorphology.
In WW Hay et al., eds., Current Pediatric Diagnosis and Treatment, 18th ed., pp. 1011–1048. New York: McGraw-Hill.
Pagana KD, Pagana TJ (2006). Mosby’s Manual of Diagnostic and Laboratory Tests, 3rd ed. St. Louis:
Mosby.
Pagon RA (2005). Genetic diagnosis and counseling. In
DC Dale, DD Federman, eds., ACP Medicine, section 3,
chap. 8. New York: WebMD.
This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.